by JapanDave

Asia Oncology Drug Marketplace Outlook to 2019 – Driven by Rising Demand and Intensifying Joint Ventures in between Firms

Asia Oncology Drug Industry Outlook to 2019 – Driven by Growing Demand and Intensifying Joint Ventures among Organizations” gives a thorough evaluation of the oncology drug marketplace in Asia. The report covers a variety of factors this kind of as industry size of oncology drugs, segmentation on the basis of therapeutic class, sorts of cancer, and volume of exports and imports for oncology drugs. The report is useful for pharmaceuticals firms, retail chains, consultants, healthcare professionals and new players venturing in the market. The industry is dominated by few worldwide players like Roche, Novartis, Pfizer and other folks.

Asia Pacific Region

The Oncology drug market place in the Asia, which is hugely driven by growing demand and investment degree of government, registered revenues of USD ~ million in 2013. With the advent of new oncology drug makers in the industry, the revenues enhanced by 7.6% in contrast to 2013 the place the complete revenues was USD ~ million. Every section in the anti-cancer drug industry is subject to a gamut of diverse aspects this kind of as prevalence rate of certain sort of cancer, price tag cuts and quantity of players in the industry plays an essential function in determining their respective revenues. The oncology drug market of Asia has grown at a CAGR of 4.3% from USD ~ million in’2009 to INR ~ million in 2014. In much more developed markets of the Asia-Pacific area, including countries this kind of as Japan and China, the offerings from the market place players are expected to be various, targeted largely on personalized demands. Moreover, the market is predicted to witness growth in terms of the newer types of medication due to the fact of increasing cancer incidence and growing awareness. The Asia-Pacific oncology drug market is expected to increase at a CAGR of 9.% from 2015-2019 on account of rising affluence of buyers towards healthier lifestyles and treatment method of cancer in the latest years.

The Asia oncology drug market place is dominated by international pharmaceuticals companies that specialize in marketing and advertising patented drugs. The market revenues of Roche from sale of anti-cancer medication have improved noticeably from USD ~ million in 2012 to USD ~ million in 2014, making it the greatest player in oncology drug area. Pfizer was the second largest player in 2014. An inclination in the death costs of cancer patients due lack of appropriate treatment supplies a huge opportunity to pharmaceutical companies to supply powerful medication in the industry and as a result contributing to larger revenue of anti-cancer drug marketplace.

India

The Oncology drug market in India, which is driven by the advancement of new option therapies, evolving move from chemotherapy to certain cancer targeted treatment, hormone treatment has registered revenues of INR ~ million in 2013. With an entry of new oncology drug producers in the sector, the revenues elevated by 65.5% in contrast to 2013 exactly where the total revenues was INR ~ million. A main issue that has contributed to this kind of a stupendous development of this marketplace is advances in technologies. Owing to the advancement in engineering, the cancer is diagnosed much regularly and as a result much better remedy can be provided to the individuals. The oncology drug market of India has grown at a CAGR of 22.% from over INR 12 billion in 2009 to INR ~ million in 2014. The primary competitors’ in India oncology space involves Cipla Ltd, Sun Pharma Ltd, Dr Reddy Laboratories amongst other people. The India oncology drug market place is expected to grow at a CAGR of 17.six% from 2015-2019 due to greater influx of patients in cancer care centers due to increasing awareness between the folks about the proper area for greatest treatment will proceed to escalate the development of oncology treatment in India.

China

Furthermore, China has witnessed continuous and significant rise in the incidence as well as death induced by cancer. This fast rise has be attributed to aspects this kind of as altering lifestyles and dietary patterns, escalating consumption of tobacco, heavy smoking and several other proximate leads to. The income of oncology market in China elevated by 15.% compared to 2013. The industry has grown at a CAGR of 17.three% from USD ~ million in 2009 to USD ~ million in 2014. The industry for oncology medicines in China is dominated by neighborhood gamers this kind of as Jiang Su Heng Rui Medication Co. Ltd, Qilu Pharmaceuticals Co. Ltd and other folks. The China oncology drug has been anticipated to incline to about USD thirty billion in 2019 from USD ~ billion in 2014. In addition, the share of generic medicines in China Oncology industry is anticipated to rise by a little percentage to around 72% in the 12 months 2019.

The market for oncology drugs in Asia is modifying at a speedy charge. Additionally, new approaching drugs, investment by government on Healthcare as nicely as aggressive pressures have been considerably modifying the industry. Revenues from the anti-cancer drug marketplace in the Asia are anticipated to broaden to USD ~ million in 2019 growing with a CAGR of ~% from 2014-2019.

Important Subjects Covered in the Report:

The industry size of the oncology drug market place in Asia
The marketplace dimension of the generic and patented medicines in Asia oncology drug marketplace.
The industry size of the local and international players industry Asia oncology drug industry.
The industry size of the India oncology and China oncology drug market.
Industry segmentation of the oncology market on the basis of type of cancer, by generic and patented drugs.
SWOT and Porter 5 force Evaluation of India and China Oncology Drug industry.
Trends and Improvement in the Asia oncology drug market place.
Government Regulations in the India and China oncology drug market place.
Aggressive landscape in depth company profiles and industry share of the key manufacturers of oncology medicines in Asia as properly as India, China and other people
Macro Economic variables affecting India and China Oncology drug market place.
Future outlook and projections of Asia Oncology drug industry on the basis of – geography.